R.H. Bluestein & Co’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,000
| Closed | -$289K | – | 401 |
|
|
2022
Q1 | $289K | Sell |
4,000
-1,296
| -24% | -$93.6K | 0.01% | 303 |
|
|
2021
Q4 | $486K | Sell |
5,296
-200
| -4% | -$18.4K | 0.02% | 220 |
|
|
2021
Q3 | $697K | Buy |
5,496
+5
| +0.1% | +$634 | 0.03% | 165 |
|
|
2021
Q2 | $913K | Sell |
5,491
-165
| -3% | -$27.4K | 0.04% | 139 |
|
|
2021
Q1 | $1.03M | Sell |
5,656
-886
| -14% | -$161K | 0.04% | 102 |
|
|
2020
Q4 | $1.31M | Buy |
6,542
+2,642
| +68% | +$528K | 0.06% | 87 |
|
|
2020
Q3 | $855K | Sell |
3,900
-580
| -13% | -$127K | 0.04% | 105 |
|
|
2020
Q2 | $855K | Buy |
4,480
+430
| +11% | +$82.1K | 0.05% | 104 |
|
|
2020
Q1 | $628K | Sell |
4,050
-3,060
| -43% | -$474K | 0.05% | 100 |
|
|
2019
Q4 | $595K | Sell |
7,110
-5,000
| -41% | -$418K | 0.03% | 136 |
|
|
2019
Q3 | $820K | Buy |
12,110
+800
| +7% | +$54.2K | 0.05% | 89 |
|
|
2019
Q2 | $751K | Buy |
11,310
+4,105
| +57% | +$273K | 0.04% | 95 |
|
|
2019
Q1 | $401K | Buy |
7,205
+2,100
| +41% | +$117K | 0.02% | 165 |
|
|
2018
Q4 | $253K | Sell |
5,105
-289,764
| -98% | -$14.4M | 0.02% | 220 |
|
|
2018
Q3 | $25.5M | Buy |
294,869
+271,569
| +1,166% | +$23.5M | 1.23% | 37 |
|
|
2018
Q2 | $1.35M | Buy |
23,300
+13,300
| +133% | +$772K | 0.07% | 59 |
|
|
2018
Q1 | $403K | Hold |
10,000
| – | – | 0.02% | 190 |
|
|
2017
Q4 | $349K | Hold |
10,000
| – | – | 0.02% | 220 |
|
|
2017
Q3 | $332K | Buy |
+10,000
| New | +$332K | 0.02% | 235 |
|